This topic contains a solution. Click here to go to the answer

Author Question: If a bond pays 11.5 percent interest a year and a bank deposit pays 3.5 percent, the opportunity ... (Read 142 times)

plus1

  • Hero Member
  • *****
  • Posts: 676
If a bond pays 11.5 percent interest a year and a bank deposit pays 3.5 percent, the opportunity cost of holding the deposit is:
 a. 11.5 percent.
  b. 15 percent.
  c. 8 percent.
  d. 3.5 percent.
  e. 13.5 percent.

Question 2

Which of the following is likely to result in a higher equilibrium price?
 a. An increase in both demand and supply.
 b. A decrease in both demand and supply.
 c. An increase in demand and a decrease in supply.
  d. A decrease in demand and an increase in supply.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Mollythedog

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

c

Answer to Question 2

c




plus1

  • Member
  • Posts: 676
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library